Moreover, despite successfully modeling FUS-CHOP-driven sarcomas in the Prrx1 tissue lineage without targeting p53 for mutation, western blot analysis of primary tumor cell lines derived from these tumors revealed that p53 protein in these tumors was either absent or nonfunctional (Figure 4(c)). This evidence concerns the gene DDIT3 and neoplasm.